These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36646786)

  • 1. Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity.
    Sampath P; Rajamanickam A; Thiruvengadam K; Natarajan AP; Hissar S; Dhanapal M; Thangavelu B; Jayabal L; Ramesh PM; Ranganathan UD; Babu S; Bethunaickan R
    Sci Rep; 2023 Jan; 13(1):785. PubMed ID: 36646786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activation of innate and adaptive lymphocytes during latent or active infection with Mycobacterium tuberculosis.
    Ruiz-Sánchez BP; Castañeda-Casimiro J; Cabrera-Rivera GL; Brito-Arriola OM; Cruz-Zárate D; García-Paredes VG; Casillas-Suárez C; Serafín-López J; Chacón-Salinas R; Estrada-Parra S; Escobar-Gutiérrez A; Estrada-García I; Hernández-Solis A; Wong-Baeza I
    Microbiol Immunol; 2022 Oct; 66(10):477-490. PubMed ID: 35856253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
    Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
    Front Immunol; 2014; 5():180. PubMed ID: 24795723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis.
    Sampath P; Rajamanickam A; Thiruvengadam K; Natarajan AP; Hissar S; Dhanapal M; Thangavelu B; Jayabal L; Ramesh PM; Ranganathan UD; Babu S; Bethunaickan R
    Sci Rep; 2023 May; 13(1):7404. PubMed ID: 37149713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicolor flow cytometric analyses of CD4+ T cell responses to Mycobacterium tuberculosis-related latent antigens.
    Yamashita Y; Hoshino Y; Oka M; Matsumoto S; Ariga H; Nagai H; Makino M; Ariyoshi K; Tsunetsugu-Yokota Y
    Jpn J Infect Dis; 2013; 66(3):207-15. PubMed ID: 23698481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.
    Sudbury EL; Clifford V; Messina NL; Song R; Curtis N
    J Infect; 2020 Dec; 81(6):873-881. PubMed ID: 33007340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis.
    Sampath P; Moorthy M; Menon A; Madhav L; Janaki A; Dhanapal M; Natarajan AP; Hissar S; Ranganathan UD; Ramaswamy G; Bethunaickan R
    Front Immunol; 2023; 14():1197805. PubMed ID: 37457712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.
    Sutherland JS; de Jong BC; Jeffries DJ; Adetifa IM; Ota MO
    PLoS One; 2010 Aug; 5(8):e12365. PubMed ID: 20811496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    J Infect; 2017 Aug; 75(2):132-145. PubMed ID: 28483404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of Mycobacterium tuberculosis-Specific and Nonspecific Immune Responses in Women with Tuberculosis Infection during Pregnancy.
    Tesfaye F; Sturegård E; Walles J; Bekele B; Bobosha K; Björkman P; Jansson M
    Microbiol Spectr; 2022 Oct; 10(5):e0117822. PubMed ID: 35969076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB.
    Marín ND; París SC; Rojas M; García LF
    Tuberculosis (Edinb); 2013 Mar; 93(2):155-66. PubMed ID: 23332142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Ottenhoff TH; Franken KL; Bjune G; Abebe F
    PLoS One; 2015; 10(4):e0124134. PubMed ID: 25897840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent M. tuberculosis infection is associated with increased inflammatory cytokine and decreased suppressor of cytokine signalling (SOCS)-3 in the diabetic host.
    Masood KI; Irfan M; Masood Q; Yameen M; Jamil B; Ram N; Rao S; Rottenberg M; Hasan Z
    Scand J Immunol; 2022 Apr; 95(4):e13134. PubMed ID: 34951048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.
    Hur YG; Gorak-Stolinska P; Ben-Smith A; Lalor MK; Chaguluka S; Dacombe R; Doherty TM; Ottenhoff TH; Dockrell HM; Crampin AC
    PLoS One; 2013; 8(11):e79742. PubMed ID: 24260295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.